Here are 1-3 brief analogies for Nu Skin Enterprises:

• The Mary Kay or Avon for anti-aging beauty and wellness.
• The Herbalife for premium anti-aging skincare and nutritional supplements.
• Imagine Mary Kay meets Herbalife, selling beauty and wellness products through direct sales.

• ageLOC Spa Systems: Anti-aging skin care systems designed to rejuvenate the skin.
• ageLOC Transformation Systems: Comprehensive anti-aging skin care systems targeting the sources of aging.
• ageLOC LumiSpa Devices: Handheld devices used for deep skin treatment and cleansing.
• ageLOC Boost: A cosmetic product that enhances skin appearance and luminosity.
• ageLOC Youth Nutritional Supplements: Supplements formulated to promote overall wellness and anti-aging benefits.
• ageLOC TR90: A weight management and body shaping system.
• LifePak Nutritional Supplements: General nutritional supplements providing essential vitamins and minerals.
• ageLOC Meta Nutritional Supplements: Specialized nutritional supplements focused on metabolic health.
• Beauty Focus Collagen+ Supplements: Supplements specifically designed to support skin health and appearance through collagen.

1. Consumers Focused on Beauty and Anti-Aging: This category includes individuals interested in skincare, anti-aging solutions, and cosmetic products. They seek to improve their appearance, reduce signs of aging, and maintain youthful skin using products such as ageLOC Spa systems, ageLOC LumiSpa, ageLOC Transformation, ageLOC Boost, and Beauty Focus Collagen+.
2. Consumers Focused on Health, Wellness, and Weight Management: This group comprises individuals who prioritize their internal health, seeking nutritional supplements, general wellness products, and weight management solutions. Products like ageLOC Youth, ageLOC TR90, LifePak, and ageLOC Meta cater to their needs for better health and physical well-being.
3. Entrepreneurs and Direct Sellers (Distributors): While also a sales channel, individuals who join Nu Skin's network as distributors are a significant customer segment. They purchase products directly from Nu Skin with the intention of reselling them to other individual consumers, often building their own sales teams. Their motivation includes both personal consumption and pursuing a business opportunity.

Ryan Napierski, Chief Executive Officer & President

Ryan Napierski has served as Nu Skin's chief executive officer and president since his appointment in March 2017. He joined Nu Skin Enterprises in 1995 and has held numerous leadership positions within the company, including president of global sales and operations, president of Nu Skin's North Asia region, and president of Nu Skin Japan. His other roles included vice president of global business development, general manager for the United Kingdom, vice president of European business development, key account manager for U.S. executives, and chief operating officer for the North Asia region. Napierski holds a bachelor's degree in business, a Master of Business Administration from Duke University, and a master's degree in international business from Goethe Universität in Germany. He also serves as the Chairman of the U.S. Direct Selling Association and holds positions on the Direct Selling Board of Directors, Direct Selling Education Foundation, and The World Federation of Direct Selling Association.

James D. Thomas, Executive Vice President, Chief Financial Officer

James D. Thomas was appointed Chief Financial Officer of Nu Skin Enterprises in 2023. Prior to this role, he served as senior vice president and chief accounting officer for the company starting in 2019. His previous experience at Nu Skin includes serving as vice president of global accounting and reporting, and vice president of finance and accountability. Thomas has been instrumental in the company's mergers and acquisitions strategy and has led various projects focused on globally aligning financial operations and identifying efficiencies to improve margins.

Joseph Y. Chang, Ph.D., Chief Scientific Officer & Executive Vice President, Product Development

Joseph Y. Chang, Ph.D., has served as Nu Skin's chief scientific officer and executive vice president of Product Development since February 2006. He possesses extensive knowledge of both the pharmaceutical and dietary supplement industries. Before joining Nu Skin, Dr. Chang was president and chief scientific officer of Pharmanex, and prior to that, he held the same positions at Binary Therapeutics, Inc. (1994-1997) and OsteoArthritis Sciences, Inc. (1991-1994). He also held executive research management roles at Wyeth-Ayerst, Rhone Poulenc Rorer, and other biotechnology companies, focusing on research for natural products related to arthritis and cancer treatment. Dr. Chang earned a B.S. degree from Portsmouth University and a Ph.D. from the University of London. He is a prolific author, having published numerous articles, reviews, and books on pharmacological research, including "The Aging Myth."

Chayce Clark, Executive Vice President and General Counsel

Chayce Clark is the executive vice president and general counsel of Nu Skin Enterprises, a role he assumed in August 2021, overseeing global legal affairs. He joined Nu Skin in 2015 as assistant general counsel and later became vice president and deputy general counsel. Prior to his tenure at Nu Skin, Clark worked as a litigation attorney at the law firm of Jones, Waldo, Holbrook & McDonough. He holds a bachelor's degree in accounting from Southern Utah University and a J.D. from the University of Utah.

Steve Hatchett, Executive Vice President, Chief Product Officer

Steve Hatchett was appointed executive vice president and chief product officer in 2021. Before this, he served as the senior vice president of global products and has been a member of Nu Skin's global management committee since 2018.

The key risks to Nu Skin Enterprises (NUS) are primarily associated with its direct selling business model, its significant reliance on the Chinese market, and broader economic factors impacting consumer spending and its salesforce.

1. Regulatory Scrutiny of Direct Selling and Challenges in the China Market: Nu Skin's direct selling model is subject to extensive global regulatory oversight, particularly in markets like China, which is crucial for the company's revenue. The company has faced past investigations and fines in China for violating direct selling laws and for misleading claims by distributors, as well as allegations of operating an illegal pyramid scheme. Any future modifications to direct selling regulations, stricter enforcement, or negative media attention in China could significantly impact Nu Skin's revenue, sales force, and business operations in this vital market.

2. Declining Sales, Shrinking Affiliate Base, and Intense Competition: Nu Skin has experienced consistent revenue declines over recent years, coupled with a significant reduction in its paid affiliates and sales leaders. The beauty, wellness, and direct selling industries are highly competitive, with evolving consumer preferences increasingly favoring social media-driven product discovery and influencer marketing over traditional direct selling methods. This competitive landscape and changing consumer habits make it challenging for Nu Skin to attract and retain distributors and maintain sales growth.

3. Macroeconomic Pressures and Impact on Consumer Spending: Economic slowdowns, inflation, tariffs, and geopolitical uncertainties negatively affect consumer spending, especially on premium beauty and wellness products, which constitute a significant portion of Nu Skin's offerings. Consumers in key markets such as Greater China, South Korea, and North America have shown caution in purchasing premium products due to these macroeconomic headwinds, impacting Nu Skin's financial performance.

1. Increasing competition from direct-to-consumer (DTC) beauty and wellness brands and broader e-commerce platforms: The market is seeing a proliferation of online-first brands in skincare, supplements, and weight management that leverage digital marketing, transparent ingredient sourcing, and competitive pricing to reach consumers directly. These brands bypass traditional multi-level marketing (MLM) structures, offering convenience and often appealing more to younger demographics who prefer online purchasing and independent product reviews over distributor relationships. This trend directly challenges Nu Skin's established distribution model and market share in its core product categories.

2. Heightened regulatory scrutiny and potential for tightened restrictions on multi-level marketing (MLM) business practices: Nu Skin operates using a direct selling model which is often subject to intense regulatory oversight concerning distributor compensation plans, earnings claims, and product efficacy substantiation. Key markets, particularly Mainland China, have historically implemented strict regulations on direct selling and anti-pyramid scheme laws. Any future tightening of these regulations, increased enforcement actions, or shifts in legal interpretations could severely impact Nu Skin's ability to operate its distributor network and recruit new participants, fundamentally challenging its core business model.

Nu Skin Enterprises (symbol: NUS) operates within several substantial addressable markets globally and in key regions like China, encompassing beauty and wellness products, nutritional supplements, and weight management solutions.

Beauty and Personal Care Products

• The global anti-aging products market was valued at $55.8 billion in 2023 and is projected to reach $108.5 billion by 2033.
• For anti-aging cosmetics, the global market size was estimated at $60.11 billion in 2025 and is predicted to increase to approximately $106.98 billion by 2035.
• The global beauty devices market is projected to rise from US$52.3 billion in 2025 to US$132.5 billion by 2032. Another estimate places the global beauty devices market size at USD 77.81 billion in 2025, expected to reach around USD 381.52 billion by 2035.
• In China, a significant market for Nu Skin, the beauty and personal care market is forecast to reach a substantial revenue of US$73.66 billion in 2025. The skincare market in China, a major segment, increased from RMB332.9 billion in 2019 to RMB461.9 billion in 2024, representing a CAGR of 6.8%.

Nutritional Supplements

• The global nutritional supplements market size was estimated at USD 517.09 billion in 2025 and is projected to reach USD 862.51 billion by 2033. Another report estimates the market at USD 412.84 billion in 2025, expected to reach around USD 808.64 billion by 2035.
• The Asia Pacific region held the largest share of the nutritional supplements market, accounting for 42.46% in 2025.

Weight Management

• The global weight management market generated a revenue of USD 142.58 billion in 2022 and is expected to reach USD 298.66 billion by 2030. Another source projects the market size to reach USD 591.7 billion in 2025 and USD 906.0 billion by 2034.
• Asia Pacific was the dominant regional market for weight management, accounting for more than 37.68% of the revenue share in 2022.

Direct Selling Channel

• The global direct selling market size was estimated at USD 237.36 billion in 2025 and is projected to reach USD 407.80 billion by 2033.
• The health & wellness segment within direct selling dominated the global market with the largest market share of 35.3% in 2025.
• Asia Pacific led the direct selling market with a share of 45.9% in 2025.

Nu Skin Enterprises (NYSE: NUS) is expected to drive future revenue growth over the next 2-3 years through several key initiatives:

1. Global Launch and Adoption of Prysm iO: Nu Skin is strategically focusing on the global launch of Prysm iO, an intelligent wellness device, with a consumer launch anticipated in the second half of 2026. This initiative is expected to stimulate growth in product subscriptions and enhance customer lifetime value.
2. Expansion into the Indian Market: The company is conducting pre-market activities and plans a full market opening in India during the latter half of 2026. This expansion is aimed at fostering sustainable, long-term growth for Nu Skin.
3. Continued Introduction and Growth of Innovative Products: Nu Skin anticipates revenue contributions from the ongoing performance of recently launched products such as ageLOC WellSpa iO, RenuSpa iO, and TRMe. Additionally, the upcoming launch of new product lines, including the MYND360 cognitive health line, is expected to further support growth.
4. Accelerated Growth of the Rhyz Ecosystem: Nu Skin is increasing investment in its Rhyz businesses, which have demonstrated significant growth, including a nearly 60% year-over-year increase in revenue in the first quarter of 2024. This focus on the Rhyz ecosystem aligns with the company's long-term vision of becoming an integrated beauty, wellness, and lifestyle platform.

Share Repurchases

• Nu Skin Enterprises repurchased approximately $20 million in shares during 2025.
• As of February 12, 2026, the company had $142.3 million remaining under its current share repurchase authorization.
• The company's 5-Year Share Buyback Ratio was 1.80% as of September 2025, indicating share buybacks over the past five years.

Outbound Investments

• In January 2025, Nu Skin Enterprises sold its Mavely affiliate marketing platform to Later for $250 million in cash and equity, which generated a five-times return on investment.

Capital Expenditures

• Capital allocation priorities include investing in innovation and growth, specifically in the build-out of its intelligent wellness platform.
• The company is focused on the global launch of its Prysm iO Intelligent Wellness device, targeting 100,000 placements by year-end 2026.
• Nu Skin is expanding its global footprint with premarket operations in India, anticipating a formal market opening in late 2026, with a focus on local infrastructure.